Scilex Holding Co
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $30.3M | $56.6M | $46.7M | $38.0M | $31.3M |
| Cost of revenue | $96.3M | $110.8M | $15.7M | $10.8M | $3.6M |
| Gross profit | $125.8M | $167.4M | — | — | — |
| Selling, general & administrative | $266.9M | $119.0M | $119.6M | $64.9M | $50.6M |
| Research and development | $20.7M | $9.6M | $12.7M | $9.1M | $9.2M |
| Operating income | -$346.0M | -$83.4M | -$105.4M | -$50.6M | -$35.8M |
| Interest expense | $11.5M | $2.0M | $1.1M | $9.6M | $11.8M |
| Pretax income | -$374.0M | -$72.8M | -$114.3M | -$23.4M | -$88.4M |
| Income tax expense | $26,000 | -$1,000 | $13,000 | $4,000 | $5,000 |
| Net income | -$374.1M | -$72.8M | -$114.3M | -$23.4M | -$88.4M |
| Balance Sheet | |||||
| Cash and equivalents | $5.0M | $3.3M | $3.9M | $2.2M | $4.3M |
| Current assets | $38.4M | $41.5M | $46.8M | $29.6M | $23.0M |
| Total assets | $365.0M | $93.0M | $101.3M | $86.5M | $77.9M |
| Current liabilities | $483.7M | $259.6M | $250.4M | $44.8M | $169.4M |
| Total liabilities | $576.7M | $285.6M | $274.2M | $50.3M | $301.8M |
| Stockholders' equity | -$207.8M | -$192.6M | -$172.9M | $36.2M | -$223.9M |
| Cash Flow Statement | |||||
| Cash from operations | $3.8M | $19.3M | -$20.7M | -$21.3M | -$28.7M |
| Depreciation and amortization | $4.6M | $4.0M | $4.1M | $4.0M | $3.8M |
| Stock-based compensation | $15.5M | $15.7M | $14.6M | $5.3M | $5.8M |
| Capital expenditure | $133,000 | $0 | $30,000 | $7,000 | $0 |
| Free cash flow | $3.7M | $19.3M | -$20.7M | -$21.3M | -$28.7M |
| Dividends paid | — | $8.7M | $8.7M | — | — |
| Impairments | $73.4M | $0 | — | — | — |
Shares outstanding 8.5M · Free float 95.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.